// App-Quantinova.ai

OP0191 : ASSOCIATION OF TRAMADOL WITH ALL-CAUSE MORTALITY, CARDIOVASCULAR DISEASE, VENOUS THROMBOEMBOLISM AND HIP FRACTURES AMONG PATIENTS WITH OSTEOARTHRITIS. A POPULATION-BASED STUDY

Researchers

Presenter

  • L. LI

Principal Investigators

  • N. Lu

  • H. Xie

  • J. Cibere

  • J. Kopec

  • J. Esdaile

  • J. A. Avia-Zubieta

Medical Centers

  • The University of British Columbia, Vancouver, BC, Canada

  • Arthritis Research Canada, Richmond,Canada

  • Simon Fraser University, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Musculoskeletal

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Osteoarthritis

Biomarkers

  • Regenerating Family Member 3 Alpha

Drug/Treatment

  • Diclofenac

  • Tramadol

  • Adolonta

  • Naproxen Sodium

  • Codeine

  • Epimorph

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A